print
VIDION beta radiation brachytherapy system for neovascular age-related macular degeneration
- Source agency:
- NHSC
- Date of Submission:
- 26/02/2010
- Date of Printing:
- 05/02/2012
- Technology name:
- VIDION
- Technology - type(s):
- Procedure, Device
- Patient indications:
- Neovascular (wet) age-related macular degeneration (AMD) in patients eligible for anti-VEGF intraocular injections such as, ranibizumab and bevacizumab.